// App-Quantinova.ai

4069 : Circulating tumor DNA dynamics in resectable gastric cancer.

Researchers

Presenter

  • Alessandro Leal

Principal Investigators

  • Jillian Phallen

  • Doreen N. Palsgrove

  • Vilmos Adleff

  • Fabienne Warmerdam

  • Donald L. Van der Peet

  • Henk M.W. Verheul

  • D. J. Van Spronsen

  • Johanna MG Van Riel

  • Maud Geenen

  • Johanna Elisabeth A. Portielje

  • Hanneke W.M. Van Laarhoven

  • Edwin PM Jansen

  • Karolina Sikorska

  • Elma Meershoek Klein Kranenbarg

  • Cornelis J. H. Van De Velde

  • Marcel Verheij

  • Annemieke Cats

  • Victor E. Velculescu

Medical Centers

  • Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Atrium Medical Center, Heerlen, Netherlands

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands

  • Caniusius Wilhelmina Hospital, Nijmegen, Netherlands

  • St Elisabeth Hospital, Tilburg, Netherlands

  • St Lucas Andreas Hospital, Amsterdam, Netherlands

  • Haga Hospitals, Den Haag, Netherlands

  • Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • The Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, Netherlands

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Leiden University Medical Centre, Leiden, Netherlands

  • Department of Radiation Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands

  • Johns Hopkins Kimmel Comprehensive Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, MD

Locations

  • United States

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT00407186

Sponsors

  • N/A

Result

  • Final